HYDROMORPHONE FORMULATIONS FOR MULTI-DOSE PRODUCTS

The present disclosure relates to a multi-dose vial presentation for hydromorphone. In particular, the present disclosure relates to terminally sterilized liquid formulations comprising hydromorphone hydrochloride packaged in a multi-dose glass vial. The present disclosure also relates to methods of...

Full description

Saved in:
Bibliographic Details
Main Authors AHMAD, Rand H, SZAKALAS-GRATZL, Gyongyi, PUSTER, Nathan, ABURMAILEH, Ragheb M
Format Patent
LanguageEnglish
French
Published 18.07.2024
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The present disclosure relates to a multi-dose vial presentation for hydromorphone. In particular, the present disclosure relates to terminally sterilized liquid formulations comprising hydromorphone hydrochloride packaged in a multi-dose glass vial. The present disclosure also relates to methods of treating patients by administration of such formulations and glass vials containing such formulations. La présente divulgation concerne une présentation de flacon multidose pour l'hydromorphone. En particulier, la présente divulgation concerne des formulations liquides stérilisées à l'extrémité comprenant du chlorhydrate d'hydromorphone conditionné dans un flacon en verre multidose. La présente invention concerne en outre des méthodes de traitement de patients par administration de ces formulations et des flacons en verre prêts à l'emploi contenant de telles formulations.
Bibliography:Application Number: WO2024US10838